← Leaderboards
Jerome E Groopman
Beth Israel Deaconess Medical Center
$14,405,534
Attributed
$15,419,847
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $918K · FY2005–21$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
Funding mix
By agency
NIH$15,419,847 · 8
By mechanism
R01$10,394,021 · 5
DP1$4,158,011 · 1
K12$484,120 · 1
R21$383,695 · 1
Top collaborators
- Thorsten Roman Mempel5 shared
Most similar at Beth Israel Deaconess Medical Center
Same institution · by research overlap
- George C Tsokos$40,494,511
- Kermit L Carraway$11,333,366
- James Burton Whitney$8,899,901
- Cornelis P Terhorst$22,963,281
- Vassiliki A Boussiotis$19,288,605
Others in their field
Top investigators on “Hiv Infections”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,259,079
- Lawrence Corey · Fred Hutchinson Cancer Center$728,701,834
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$467,263,656
- Judith S. Currier · University Of California Los Angeles$466,447,923
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
Research focus
Hiv InfectionsVirusCellsTransmission ProcessInnovationImmuneHuman Immunodeficiency Virus 1LymphaticMolecular PathologyReceptorMolecularHiv-1LigandsAcquired Immunodeficiency SyndromeFoundationsSynapsesTissue /Cell CultureReceptor ExpressionPreventMediatingHiv Envelope Protein Gp120Pathway InteractionsApoptosisComplex
Grant awards (39)
Cocaine induces production of infectious large extracellular vesicles (lEV) and regulates neuro-inflammation$383,695
R21 · FY2021 · DA · contact PI
Novel Mechanisms of Disarming Anti-HIV Host Defenses by Methamphetamine$349,488
R01 · FY2019 · DA · contact PI
Novel Mechanisms of Disarming Anti-HIV Host Defenses by Methamphetamine$349,488
R01 · FY2018 · DA · contact PI
Novel Strategies to Antagonize Cocaine-Enhanced HIV Pathobiology$404,046
R01 · FY2017 · DA · contact PI
Novel Mechanisms of Disarming Anti-HIV Host Defenses by Methamphetamine$349,488
R01 · FY2017 · DA · contact PI
Novel Strategies to Antagonize Cocaine-Enhanced HIV Pathobiology$400,004
R01 · FY2016 · DA · contact PI
Novel Mechanisms of Disarming Anti-HIV Host Defenses by Methamphetamine$345,993
R01 · FY2016 · DA · contact PI
Novel Strategies to Antagonize Cocaine-Enhanced HIV Pathobiology$397,984
R01 · FY2015 · DA · contact PI
Novel Mechanisms of Disarming Anti-HIV Host Defenses by Methamphetamine$367,740
R01 · FY2015 · DA · contact PI
Novel Strategies to Antagonize Cocaine-Enhanced HIV Pathobiology$404,046
R01 · FY2014 · DA · contact PI
Novel Strategies to Antagonize Cocaine-Enhanced HIV Pathobiology$422,546
R01 · FY2013 · DA · contact PI
Inhibition of HIV at the Immune Synapse Utilizing Novel Ligands and Receptors$800,256
DP1 · FY2012 · DA · contact PI
Inhibition of HIV at the Immune Synapse Utilizing Novel Ligands and Receptors$816,255
DP1 · FY2011 · DA · contact PI
Inhibition of HIV at the Immune Synapse Utilizing Novel Ligands and Receptors$841,500
DP1 · FY2010 · DA · contact PI
Inhibition of HIV at the Immune Synapse Utilizing Novel Ligands and Receptors$850,000
DP1 · FY2009 · DA · contact PI
Inhibition of HIV at the Immune Synapse Utilizing Novel Ligands and Receptors$850,000
DP1 · FY2008 · DA · contact PI
Functional Studies of HIV-Tat Effects on Endothelium$68,000
R01 · FY2008 · HL · contact PI
Functional Studies of HIV-Tat Effects on Endothelium$332,010
R01 · FY2007 · HL · contact PI
Functional Studies of HIV-Tat Effects on Endothelium$17,000
R01 · FY2007 · HL · contact PI
Functional Studies of HIV-Tat Effects on Endothelium$332,010
R01 · FY2006 · HL · contact PI
Functional Studies of HIV-Tat Effects on Endothelium$17,000
R01 · FY2006 · HL · contact PI
Functional Studies of HIV-Tat Effects on Endothelium$340,000
R01 · FY2005 · HL
Pathogenesis of Hepatic Injury with HCV/HIV Coinfection$340,000
R01 · FY2005 · DA
PATHOBIOLOGY OF HIV SUPPRESSION OF HEMATOPOIESIS$445,541
R01 · FY2004 · HL
Functional Studies of HIV-Tat Effects on Endothelium$340,000
R01 · FY2004 · HL
Pathogenesis of Hepatic Injury with HCV/HIV Coinfection$340,000
R01 · FY2004 · DA
PATHOBIOLOGY OF HIV SUPPRESSION OF HEMATOPOIESIS$432,564
R01 · FY2003 · HL
Pathogenesis of Hepatic Injury with HCV/HIV Coinfection$340,000
R01 · FY2003 · DA
Functional Studies of HIV-Tat Effects on Endothelium$340,000
R01 · FY2003 · HL
PATHOBIOLOGY OF HIV SUPPRESSION OF HEMATOPOIESIS$423,102
R01 · FY2002 · HL
Pathogenesis of Hepatic Injury with HCV/HIV Coinfection$340,000
R01 · FY2002 · DA
FUNCTIONAL STUDIES OF HIV-TAT EFFECTS ON ENDOTHELIUM$304,500
R01 · FY2002 · HL
Pathogenesis of Hepatic Injury with HCV/HIV Coinfection$85,000
R01 · FY2002 · DA
PATHOBIOLOGY OF HIV SUPPRESSION OF HEMATOPOIESIS$413,920
R01 · FY2001 · HL
Pathogenesis of Hepatic Injury with HCV/HIV Coinfection$340,000
R01 · FY2001 · DA
FUNCTIONAL STUDIES OF HIV-TAT EFFECTS ON ENDOTHELIUM$304,500
R01 · FY2001 · HL
AIDS-ONCOLOGY CLINICAL SCIENTIST DEVELOPMENT PROGRAM$484,120
K12 · FY2000 · CA
PATHOBIOLOGY OF HIV SUPPRESSION OF HEMATOPOIESIS$403,551
R01 · FY2000 · HL
FUNCTIONAL STUDIES OF HIV-TAT EFFECTS ON ENDOTHELIUM$304,500
R01 · FY2000 · HL